Philmans Pharm, Cenedella.de, The German Patient Roundtable

Est. 1977

Isodiol Participates in World of Cannabis Summit, Continues National PSA of Addressing Opioid Addiction with Cannabinoids

Isodiol Will Join Industry Experts from Columbia, South America, Canada, U.S.A. and the Caribbean at the Palms Hotel in Las Vegas November 15-16 for the World of Cannabis Summit and Sponsors Dr. David Tonkin and Marvin Washington in Panel Discussions on Pain Management and Addressing Opioid Addiction with Cannabis

isodiol-homepage

CARLSBAD, CA / ACCESSWIRE / November 10, 2016 / Isodiol, the Southern California-based hemp cannabidiol CBD innovator, is proud to announce that the Company will have a major presence at the World of Cannabis conference at The Palms hotel in Las Vegas November 15-16. Isodiol’s participation at World of Cannabis adds a significant component to the global cannabis commerce landscape. The Company’s revolutionary nano-amplified cannabinoids are added to consumer products or can be supplied to manufacturers as a raw ingredient. Isodiol’s products contain no THC and are derived from the mature stalk of the industrial hemp plant and, therefore, can be shipped anywhere in the world where hemp products are sold.

“Participating in the World of Cannabis conference emphasizes our global initiative to increase awareness and availability of nano-amplified cannabinoids in consumer products,” states Jared Berry, CEO of Isodiol. “We are truly honored to have a substantial presence at this unique international conference and look forward to sharing our industry insights with conference participants from around the world.”

Recently announced was Isodiol’s role in fostering multimillion dollar acquisitions by Canadian-based Laguna Blends Inc. (CSE: LAG) (OTC: LAGBF) (Frankfurt: LB6A.F). Laguna Blends subsequently announced its sales expansion plans into Japan, South Korea, Thailand and Germany with consumer products containing nano-amplified cannabinoids by Isodiol.

Isodiol: A Committed Community Outreach Partner

Isodiol is continuing to increase public awareness that cannabis addresses the nation’s #1 health epidemic: opioid addiction. At the World of Cannabis Summit, Isodiol has arranged for renowned pain specialist, Dr. David Tonkin, to join the panel discussion titled “Cannabis: Solution to the Opioid Epidemic”. Also made possible by Isodiol is the participation by 11-year NFL veteran and Super Bowl winner, Marvin Washington, who is a vocal advocate on the resurgence of cannabis as a global industry. Washington will answer questions on his personal experience in professional sports during the panel discussion “Miracle of the Cannabinoid System”.

For details on the World of Cannabis conference, visit http://worldofcannabissummit.com/

Members of the media: For press interviews and press passes, please contact Denise Mahaffey at 760.908.6565 or email to media@isodiol.com

About Laguna Blends, Inc.

Laguna Blends Inc. (CSE: LAG) (OTC: LAGBF) (Frankfurt: LB6A.F) is engaged in development, sales, marketing and distribution of hemp based products and solutions. Laguna specializes in identifying emerging trends and opportunities such as cannabidiol CBD, one of the most useful compounds found in the hemp plant.

Laguna Blends is currently seeking joint ventures and acquisitions to expand its portfolio in the hemp and cannabinoid markets. To learn more, visit www.LagunaBlendsInc.com, Facebook and YouTube.

About Isodiol:

Isodiol and its team of collaborators are a group of companies that together, grow & harvest hemp on an industrial scale, and then process it to extract the non-psychoactive cannabidiol CBD to the highest available purity for worldwide distribution. By utilizing one of the world’s largest hemp farms, Isodiol and its partners are the choice for industrial volumes of high-grade, non-psychoactive CBD. Pharmaceutical, nutraceutical and cosmetic companies worldwide have gained market share due to our products. For more information, visit www.Isodiol.com. To follow Isodiol online, visit the Company’s website at http://www.isodiol.com, Facebook, Instagram, and Twitter.

Contact:

Denise Mahaffey
Media@isodiol.com
760.908.6565

LEGAL DISCLOSURE

Isodiol does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). Cannabidiol is a natural element of industrial hemp. Isodiol’s products are not intended to cure, mitigate or diagnose disease states.

SOURCE: Isodiol

Author: Cenedella.de

Over the last 4 decades I have been involved in the fight for patient rights in America, and now here in Germany. During my career I have served as a Board of Director for the World Trade Center San Diego and as a Lead Consultant for Deutsche Telekom's Executive Board, Co-Founded the San Diego Software Council and the Dayton Human Trafficking Accords and was Director of LawInfo's Lead Council Program. Previously I was a C-Level Business Development Executive in the technology sector, but also involved with the cannabis industry since 1977. More recently I have been fulltime in the legal medical marijuana industry here in Europe, helping international companies navigate the biggest potential market in the world. This website is light on details due to confidentiality issues with clients but be rest assured I am knowledgeable, professional and with street cred in the industry that can immediately assist your growth in some way. Consulting Services: Sales and Business Development Assist with Strategic Direction Professionally represent your firm Special Projects management Licensing and compliance Sales and Distribution networks Qualify potential partners I am your resource on the ground in Europe, contact me directly to schedule an initial discussion on the German Cannabis-as-Medicine market. Thank you, Philip J. Cenedella IV Call +1.888.206.3264 USA +49.0.151.720.17652 GERMANY Skype: philip.j.cenedella eMail: phil@cenedella.de LinkedIN: https://www.linkedin.com/in/cenedellade/

Comments are closed.